Momenta Pharmaceuticals, Inc. (MNTA)

[Boing x 2]

Floblu and Funindasun,

I agree with both of you.

MNTA has enough informations from the clinical trials to go to the FDA and say there should be a trial with this known safe dose, from our on going clinical trial, which already has shown effect at a low dose.

What have they got to loose. There have been no major problems on their regular clinical trial.

Only one donor of Covid-19 plasma isn't going to cut it to do an enormous population of infected people.

Only MNTA has the ability to make the IVIg go further with their patented process.

Good question for the up coming quarterly conference call.

Floblu you have the inside track on getting this question answered.

Boing X 2